Prospective Multicenter Randomized Openlabel Study to Evaluate the Benefit on Renal Function at 12months Post-transplantation of Immunosuppressive Treatment With Withdrawal of Calcineurin Inhibitor at 3months and Combining Mycophenolate Sodium-Everolimus Versus Tacrolimus-Everolimus, in Patients With de Novo Kidney Transplant
Phase of Trial: Phase III
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Mycophenolate sodium (Primary) ; Everolimus; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 24 Jul 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 24 Jul 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 14 Jan 2015 New trial record